S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
10 Ways Entrepreneurs Can Navigate a Down Economy
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Drought-struck Barcelona quenches thirst with costly desalination
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
10 Ways Entrepreneurs Can Navigate a Down Economy
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Drought-struck Barcelona quenches thirst with costly desalination
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
10 Ways Entrepreneurs Can Navigate a Down Economy
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Drought-struck Barcelona quenches thirst with costly desalination
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
Stock market today: Markets mostly higher after Biden-McCarthy deal on US debt
Free A.I. Trade Alerts. Up to 15 opportunities a day. (Ad)
Text released of 99-page bill to raise debt limit, curb spending; lawmakers to review as House eyes Wednesday vote
10 Ways Entrepreneurs Can Navigate a Down Economy
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
PwC Australia sidelines 9 directors as leak of tax information investigated
South African president appoints judge to oversee weapons-for-Russia inquiry
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Drought-struck Barcelona quenches thirst with costly desalination
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
NASDAQ:KMDA

Kamada (KMDA) Stock Forecast, Price & News

$5.31
-0.08 (-1.48%)
(As of 05/26/2023 04:00 PM ET)
Compare
Today's Range
$5.21
$5.44
50-Day Range
$4.24
$5.40
52-Week Range
$3.72
$5.72
Volume
112,500 shs
Average Volume
35,397 shs
Market Capitalization
$237.99 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.00

Kamada MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
107.2% Upside
$11.00 Price Target
Short Interest
Healthy
0.01% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.58mentions of Kamada in the last 14 days
Based on 25 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
100.00%
From $0.09 to $0.18 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.67 out of 5 stars

Medical Sector

90th out of 1,010 stocks

Pharmaceutical Preparations Industry

32nd out of 494 stocks


KMDA stock logo

About Kamada (NASDAQ:KMDA) Stock

Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, which are manufactured by third parties. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.

Receive KMDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kamada and its competitors with MarketBeat's FREE daily newsletter.

KMDA Stock News Headlines

Free SMS Trade Alerts. Up to 15 opportunities a day.
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
StockNews.com Initiates Coverage on Kamada (NASDAQ:KMDA)
Kamada: Q1 Earnings Insights
3 Free Stock Picks per Day
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
Kamada: Q1 Earnings Snapshot
Here's what Wall Street expects from Kamada's earnings
Kamada Q1 2023 Earnings Preview
Kamada Earnings Preview
StockNews.com Upgrades Kamada (NASDAQ:KMDA) to "Buy"
See More Headlines
Receive KMDA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kamada and its competitors with MarketBeat's FREE daily newsletter.

KMDA Company Calendar

Last Earnings
3/15/2023
Today
5/29/2023
Next Earnings (Estimated)
8/16/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:KMDA
Employees
355
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$11.00
High Stock Price Forecast
$11.00
Low Stock Price Forecast
$11.00
Forecasted Upside/Downside
+107.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-2,320,000.00
Pretax Margin
-1.72%

Debt

Sales & Book Value

Annual Sales
$129.34 million
Cash Flow
$0.03 per share
Book Value
$3.93 per share

Miscellaneous

Free Float
28,640,000
Market Cap
$237.99 million
Optionable
Not Optionable
Beta
0.99

Key Executives

  • Amir London
    Chief Executive Officer
  • Eran Nir
    Chief Operating Officer
  • Naveh Tov
    VP-Clinical Development & Medical Director
  • Nir Livneh
    Secretary, Vice President & General Counsel
  • Boris Gorelik
    VP-Business Development & Strategic Programs













KMDA Stock - Frequently Asked Questions

Should I buy or sell Kamada stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Kamada in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" KMDA shares.
View KMDA analyst ratings
or view top-rated stocks.

What is Kamada's stock price forecast for 2023?

1 analysts have issued twelve-month price objectives for Kamada's stock. Their KMDA share price forecasts range from $11.00 to $11.00. On average, they expect the company's stock price to reach $11.00 in the next year. This suggests a possible upside of 107.2% from the stock's current price.
View analysts price targets for KMDA
or view top-rated stocks among Wall Street analysts.

How have KMDA shares performed in 2023?

Kamada's stock was trading at $4.01 on January 1st, 2023. Since then, KMDA shares have increased by 32.4% and is now trading at $5.31.
View the best growth stocks for 2023 here
.

Are investors shorting Kamada?

Kamada saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 5,400 shares, a decline of 60.6% from the April 30th total of 13,700 shares. Based on an average daily trading volume, of 20,300 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.0% of the company's shares are sold short.
View Kamada's Short Interest
.

When is Kamada's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 16th 2023.
View our KMDA earnings forecast
.

How were Kamada's earnings last quarter?

Kamada Ltd. (NASDAQ:KMDA) posted its quarterly earnings results on Wednesday, March, 15th. The biotechnology company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.04. The biotechnology company earned $45.44 million during the quarter, compared to analysts' expectations of $44.64 million. Kamada had a negative net margin of 1.74% and a positive trailing twelve-month return on equity of 8.15%.

What guidance has Kamada issued on next quarter's earnings?

Kamada issued an update on its FY 2023 earnings guidance on Friday, May, 26th. The company provided EPS guidance of for the period. The company issued revenue guidance of $138.00 million-$146.00 million, compared to the consensus revenue estimate of $141.36 million.

What other stocks do shareholders of Kamada own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kamada investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Athabasca Oil (ATH), Allergan (AGN), NIC (EGOV), Micron Technology (MU), Teva Pharmaceutical Industries (TEVA) and Aegean Marine Petroleum Network (ANW).

What is Kamada's stock symbol?

Kamada trades on the NASDAQ under the ticker symbol "KMDA."

Who are Kamada's major shareholders?

Kamada's stock is owned by many different retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (1.89%), Acadian Asset Management LLC (1.44%), Altshuler Shaham Ltd (0.79%), Meitav Investment House Ltd. (0.15%) and UBS Group AG (0.11%).

How do I buy shares of Kamada?

Shares of KMDA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Kamada's stock price today?

One share of KMDA stock can currently be purchased for approximately $5.31.

How much money does Kamada make?

Kamada (NASDAQ:KMDA) has a market capitalization of $237.99 million and generates $129.34 million in revenue each year. The biotechnology company earns $-2,320,000.00 in net income (profit) each year or ($0.05) on an earnings per share basis.

How many employees does Kamada have?

The company employs 355 workers across the globe.

How can I contact Kamada?

Kamada's mailing address is 2 HOLTZMAN ST. SCIENCE PARK, REHOVOT L3, 7670402. The official website for the company is www.kamada.com. The biotechnology company can be reached via phone at (728) 940-6472, via email at ir@kamada.com, or via fax at 972-8940-6473.

This page (NASDAQ:KMDA) was last updated on 5/29/2023 by MarketBeat.com Staff

My Account -